Cefpirome
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
43.00 |
|
30 |
No use |
10.00 |
|
30 |
|
Ceftiofur
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
40.00 |
|
30 |
No use |
16.00 |
|
30 |
|
Ampicillin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
100.00 |
|
30 |
No use |
87.00 |
|
30 |
|
Amoxicillin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
100.00 |
|
30 |
No use |
87.00 |
|
30 |
|
Amikacin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
0.00 |
|
30 |
No use |
0.00 |
|
30 |
|
Enrofloxacin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
23.00 |
|
30 |
No use |
23.00 |
|
30 |
|
Marbofloxacin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
23.00 |
|
30 |
No use |
15.00 |
|
30 |
|
Chloramphenicol
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
53.00 |
|
30 |
No use |
36.00 |
|
30 |
|
Sulfamethoxazole And Trimethoprim
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
47.00 |
|
30 |
No use |
27.00 |
|
30 |
|
Tetracycline
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
93.00 |
|
30 |
No use |
100.00 |
|
30 |
|
Gentamicin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
66.00 |
|
30 |
No use |
20.00 |
|
30 |
|
Tobramycin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
63.00 |
|
30 |
No use |
23.00 |
|
30 |
|
Cefalexin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
43.00 |
|
30 |
No use |
16.00 |
|
30 |
|
Cefpodoxime
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
43.00 |
|
30 |
No use |
16.00 |
|
30 |
|
Nitrofurantoin
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
52.00 |
|
30 |
No use |
22.00 |
|
30 |
|
Amoxicillin And Beta-Lactamase Inhibitor
/
|
Escherichia coli
|
See: Figure 1 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
0.00 |
|
30 |
No use |
0.00 |
|
30 |
|
See Gene Column
TEM (family) (NA)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
100.00 |
|
30 |
No use |
87.00 |
|
30 |
|
See Gene Column
CTX-M-1 (ARO:3001864)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
32.50 |
|
30 |
No use |
10.00 |
|
30 |
|
See Gene Column
CTX-M-8 (ARO:3001871)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
0.00 |
|
30 |
No use |
0.00 |
|
30 |
|
See Gene Column
CTX-M-9 (ARO:3001872)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
10.00 |
|
30 |
No use |
0.00 |
|
30 |
|
See Gene Column
aadA (ARO:3002601)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
67.00 |
|
30 |
No use |
17.00 |
|
30 |
|
See Gene Column
aadA2 (ARO:3002602)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
52.00 |
|
30 |
No use |
12.00 |
|
30 |
|
See Gene Column
ANT(2)-Ia (ARO:3000230)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
52.00 |
|
30 |
No use |
17.50 |
|
30 |
|
See Gene Column
tet(A) (ARO:3000165)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
90.00 |
|
30 |
No use |
96.00 |
|
30 |
|
See Gene Column
tet(B) (ARO:3000166)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
40.00 |
|
30 |
No use |
32.50 |
|
30 |
|
See Gene Column
sul1 (ARO:3000410)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
36.00 |
|
30 |
No use |
30.00 |
|
30 |
|
See Gene Column
sul2 (ARO:3000412)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
23.00 |
|
30 |
No use |
20.00 |
|
30 |
|
See Gene Column
sul3 (ARO:3000413)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
14.00 |
|
30 |
No use |
12.00 |
|
30 |
|
See Gene Column
dfrA1 (ARO:3002854)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
30.00 |
|
30 |
No use |
30.00 |
|
30 |
|
See Gene Column
dfrA10 (ARO:3003011)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
18.00 |
|
30 |
No use |
17.00 |
|
30 |
|
See Gene Column
dfrA12 (ARO:3002858)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
12.50 |
|
30 |
No use |
22.50 |
|
30 |
|
See Gene Column
catA (not_assigned)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
36.00 |
|
30 |
No use |
38.00 |
|
30 |
|
See Gene Column
catB (not_assigned)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
26.00 |
|
30 |
No use |
20.00 |
|
30 |
|
See Gene Column
mdfA (ARO:3001328)
/
|
Escherichia coli
|
See: Figure 2 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Tiamulin and amoxicillin use |
20.00 |
|
30 |
No use |
10.00 |
|
30 |
|